This study thoroughly examined the expression levels, clinical features, biological functions, and prognostic value of NSUN5 in gliomas, utilizing a training cohort of 325 patients from the Chinese Glioma Genome Atlas (CGGA) and a validation cohort of 702 patients from The Cancer Genome Atlas (TCGA). The gene discussed is NSUN5; the disease is central nervous system cancer.